Argos Therapeutics (ARGS) Misses Q1 EPS by 9c

Argos Therapeutics (NASDAQ: ARGS) reported Q1 EPS of ($0.89), $0.09 worse than the analyst estimate of ($0.80). Revenue for the quarter came in at $178.8 thousand versus the consensus estimate of $270 thousand.

For earnings history and earnings-related data on Argos Therapeutics (ARGS) click here.

You May Also Be Interested In

• Tesla to launch Cybercab in Austin this month - report
• Is Treasury selloff a major issue for stock market bulls?
• BitFuFu Inc. (FUFU) Misses Q2 EPS by 13c